Biological properties of synthetic glycoconjugate mimics of heparin comprising different molecular spacers.
The in vitro antithrombotic activity of synthetic glycoconjugates I and II, comprising a flexible polyethylene glycol type and a rigid polyglucose type spacer, respectively, are compared to heparin.